Report cover image

Global Medicine Pipeline Market Growth (Status and Outlook) 2024-2030

Publisher LP Information, Inc.
Published Nov 12, 2024
Length 102 Pages
SKU # LPI19318089

Description

Global Medicine Pipeline Market Growth (Status and Outlook) 2024-2030


The Medicine pipeline refers to a series of steps and processes taken by pharmaceutical companies or research institutions when discovering and developing new drugs. These steps usually include drug discovery, preclinical research, clinical trials, application for marketing, and post-marketing research and monitoring. The purpose of the drug pipeline is to ensure that new drugs meet standards in terms of safety and efficacy so that they can be successfully marketed and used to treat diseases.

The global Medicine Pipeline market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.

LPI (LP Information)' newest research report, the “Medicine Pipeline Industry Forecast” looks at past sales and reviews total world Medicine Pipeline sales in 2022, providing a comprehensive analysis by region and market sector of projected Medicine Pipeline sales for 2023 through 2029. With Medicine Pipeline sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Medicine Pipeline industry.

This Insight Report provides a comprehensive analysis of the global Medicine Pipeline landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Medicine Pipeline portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Medicine Pipeline market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Medicine Pipeline and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Medicine Pipeline.

United States market for Medicine Pipeline is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Medicine Pipeline is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Medicine Pipeline is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Medicine Pipeline players cover Roche, Pfizer, AstraZeneca, Eli Lilly, Bristol Myers Squibb, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Medicine Pipeline market by product type, application, key players and key regions and countries.

Segmentation by Type:
Innovative Drugs
Generic Drugs

Segmentation by Application:
Pharmaceutical Industry
Biotechnology
Public Health
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Segmentation by Type:
Innovative Drugs
Generic Drugs

Segmentation by Application:
Pharmaceutical Industry
Biotechnology
Public Health
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Roche
Pfizer
AstraZeneca
Eli Lilly
Bristol Myers Squibb
Novartis
Johnson & Johnson
Jiangsu Hengrui Pharmaceuticals
Merck
Sanofi
APC
AbbVie
Moderna
Prime Medicine

Please note: The report will take approximately 2 business days to prepare and deliver.

Table of Contents

102 Pages
*This is a tentative TOC and the final deliverable is subject to change.*
1 Scope of the Report
2 Executive Summary
3 Medicine Pipeline Market Size by Player
4 Medicine Pipeline by Region
5 Americas
6 APAC
7 Europe
8 Middle East & Africa
9 Market Drivers, Challenges and Trends
10 Global Medicine Pipeline Market Forecast
11 Key Players Analysis
12 Research Findings and Conclusion

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us